Nanobody
NiV_RBinder_003|Nanobody
Sequence (111 AA)
QVQLQESGGGSVQGGGSLRLSCAASGFTFSSQRFYCWVRQAPGKMWEWISDFNNWDEKRFTISRDSFKQTLYLEMNSLKFEDTFVYYCAAVKFLRFHYPKWGQATQMTVSS
No experimental data
This protein hasn't been validated in the lab yet.
This protein was designed using JORational Antibody-Based Binder Design (RABBD)
Camelid VHH domain; CDR1 Design: Alternative aromatic pattern (R, F, Y); CDR2 Design: Different charge distribution for conformational epitope; CDR3 Design: Extended (11 residues) for allosteric site binding; Epitope Target: Conformational epitope; Optimization: 10 mutations for novelty; ipSAE Target: >36